Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 7 (3), 322-6

Tapentadol Hydrochloride: A Novel Analgesic

Affiliations
Review

Tapentadol Hydrochloride: A Novel Analgesic

Dewan Roshan Singh et al. Saudi J Anaesth.

Abstract

Tapentadol is a novel, centrally acting analgesic with dual mechanism of action, combining mu-opioid receptor agonism with noradrenaline reuptake inhibition in the same molecule. It has an improved side effect profile when compared to opioids and nonsteroidal anti-inflammatory drugs. The dual mechanism of action makes Tapentadol a useful analgesic to treat acute, chronic, and neuropathic pain.

Keywords: Nonsteroidal anti-inflammatory drugs; opioids; tapentadol hydrochloride.

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Chemical structure of Tapentadol

Similar articles

See all similar articles

Cited by 8 PubMed Central articles

See all "Cited by" articles

References

    1. Brown AK, Christo PJ, Wu CL. Strategies for postoperative pain management. Best Pract Res Clin Anaesthesiol. 2004;18:703–17. - PubMed
    1. Power I, Barratt S. Analgesic agents for the postoperative period: Nonopioids. Surg Clin North Am. 1999;79:275–95. - PubMed
    1. Stephens J, Laskin B, Pashos C, Pena B, Wong J. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors. Rheumatology (Oxford) 2003;42:40–52. - PubMed
    1. McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296:1633–44. - PubMed
    1. Hatrick CT. Tapentadol immediate release for the relief of moderate-to-severe acute pain. Expert Opin Pharmacother. 2009;10:2687–96. - PubMed
Feedback